Does TIRAGOLUMAB Cause Intentional product use issue? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Intentional product use issue have been filed in association with TIRAGOLUMAB. This represents 4.1% of all adverse event reports for TIRAGOLUMAB.
23
Reports of Intentional product use issue with TIRAGOLUMAB
4.1%
of all TIRAGOLUMAB reports
6
Deaths
1
Hospitalizations
How Dangerous Is Intentional product use issue From TIRAGOLUMAB?
Of the 23 reports, 6 (26.1%) resulted in death, 1 (4.3%) required hospitalization.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRAGOLUMAB. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does TIRAGOLUMAB Cause?
Off label use (58)
Hyperthyroidism (39)
Pneumonia (29)
Pneumonitis (26)
Infusion related reaction (23)
Death (21)
Adrenal insufficiency (20)
Troponin increased (20)
Colitis (15)
Febrile neutropenia (14)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which TIRAGOLUMAB Alternatives Have Lower Intentional product use issue Risk?
TIRAGOLUMAB vs TIRBANIBULIN
TIRAGOLUMAB vs TIRZEPATIDE
TIRAGOLUMAB vs TISLELIZUMAB
TIRAGOLUMAB vs TISOTUMAB VEDOTIN
TIRAGOLUMAB vs TISOTUMAB VEDOTIN-TFTV